Tori Marsh - July 02, 2018
Proair, Advair, and Singulair — these are some of the many popular asthma medications that can cost upwards of $500 per month. To combat these high prices, many rely on their insurance coverage to shoulder the cost. But over the past couple of years, it seems like even insured individuals are paying higher out-of-pocket costs for their lifesaving prescriptions, especially in the case of asthma medications. See More
Benita Lee - June 22, 2018
As with other forms of coverage restrictions, insurance plans use quantity limits to ensure patient safety and control healthcare costs. Quantity limits define how much of a drug you can fill during a specific time period, but they can be a hassle. Here’s how to navigate your plan’s policies, so you can still get the medications you need.
How do quantity limits work?
Generally speaking, plans will review clinical and FDA literature to decide how much of a drug they will cover in a certain time period. See More
Katie Mui - May 19, 2018
It’s no secret that asthma inhalers have gotten expensive, and there are no signs of soaring prices slowing down. Even under Medicare Part D, asthma inhalers are high-ticket drugs. They’re listed under Medicare’s higher-tier, “non-preferred” or “specialty” drug categories, which pushes the cost of these medications onto the 43 million Americans enrolled in Part D.
Whether or not you’re enrolled in Medicare, asthma inhalers can be pricey. See More
Tori Marsh - April 18, 2018
In 2013, the New York Times published an expose on the high price of asthma inhalers, in an article headlined “The Soaring Cost of a Simple Breath.”
So what’s happened in the 5 years since? Prices have only gotten worse.
A GoodRx analysis of cash prices for asthma inhalers shows that prices have climbed about 35% since 2013, from an average price of around $280 in 2013 to more than $380 today.
Jeroen van Meijgaard - March 23, 2018
Prescriptions for asthma inhalers surged by over 40% in the San Francisco Bay Area in the month of last October’s Northern California fires in Napa and Sonoma counties, according to a GoodRx analysis of pharmacy data.
In Marin County, inhaler prescriptions climbed by 78% in Oct. 2017, with prescriptions in Napa rising by 67% and San Francisco, Sonoma, and Contra Costa climbing by about 50% in the month during the fires. See More
Tori Marsh - January 12, 2018
With cash prices for inhaler Advair (fluticasone/salmeterol) reaching well beyond $400, there has been anticipation for the release of a generic. But as of February 8th, 2018, the release of Advair’s generic was postponed, despite the FDA’s previous acceptance of Sandoz’s application.
According to Sandoz, the manufacturer of generic medications owned by Novartis, the FDA has declined to approve the generic application and is asking for more data on the Advair substitute. See More
Tori Marsh - December 15, 2017
Symbicort (budesonide/formoterol) is a common maintenance inhaler, taken on a daily basis to treat asthma and COPD, but it’s not cheap. Cash prices average around $323 for one inhaler, and out of pocket costs for those who fill Symbicort regularly can be unmanageable.
Symbicort works well. Around 60% of people rate that Symbicort is ‘worth it’, according to our friends at Iodine. If Symbicort works well for you, or your doctor thinks it’s best for you, how can you make it more affordable? Here’s some information about Symbicort and how you can save. See More
Dr. Sharon Orrange - August 03, 2017
Combination inhalers prescribed for asthma, smoking lung disease (COPD), or persistent cough after an upper respiratory infection are some of the top selling drugs in the United States. Several steroid + long acting bronchodilator combinations are currently available: the older Advair and Symbicort and the newer Dulera and Breo Ellipta.